Ingeborg and Erwin Hochmair, founders of MED-EL and internationally recognized pioneers in hearing implant technology, have been awarded the 2026 Richard N. Merkin Prize in Biomedical Technology.
Continue reading at AudiologyOnline
✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this is an awards announcement with no new clinical data or practice implications.
✦ Why It Matters ✦
Recognition of the Hochmairs' decades-long contributions underscores the transformative impact cochlear implant technology has had on the audiology field and on millions of patients worldwide.
✦ Key Points ✦
- 01MED-EL founders Ingeborg and Erwin Hochmair received the 2026 Richard N. Merkin Prize in Biomedical Technology.
- 02The prize honours their pioneering role in developing hearing implant technology.
- 03The award highlights cochlear implants as a landmark biomedical engineering achievement.
- 04No new clinical data, products, or regulatory decisions are announced.